JelikaLite has been awarded Technology Enhancement for Commercial Partnerships (TECP) grant from the NSF
JelikaLite has been awarded Technology Enhancement for Commercial Partnerships (TECP) grant from the NSF
JelikaLite
  • Products
  • Science
  • Autism
  • Company
  • Press & News
  • linkedin
Sign up for Early Access

Archives: Team

October 14, 2021
Sander Koyfman, MD
Learn More
October 14, 2021
Baruch Ben Dor, DsC
Learn More
October 14, 2020
Ruby Thoms
Learn More

Posts navigation

Newer posts

Recent Posts

  • JelikaLite Inc. has been awarded a $189,000 Technology Enhancement for Commercial Partnerships (TECP) grant from the U.S. National Science Foundation (NSF)
  • We’re thrilled to share a significant achievement for JelikaLite. Our groundbreaking study, “Transcranial photobiomodulation for reducing symptoms of autism spectrum disorder and modulating brain electrophysiology in children aged 2–7: an open label study” has been published in Frontiers in Child and Adolescent Psychiatry 📚.
  • JelikaLite has been awarded a 2-year, $959,000 National Science Foundation (NSF) grant to develop a non-invasive therapeutic brain stimulation medical device to improve the communication, responsiveness, and social integration of autistic children.  The project’s objectives are to finalize the current clinical prototype into a manufacturing-ready product and implement a platform for personalizing transcranial photobiomodulation (tPBM) treatment based on individual sensor -derived patient characteristics. Results could enrich scientific knowledge through personalization, monitoring, and data aggregation of neurological measures for further elucidating the mechanisms of autism and enhancing the efficacy of other therapies. Read more here https://lnkd.in/e23Yj74y.
  • We’re thrilled to share a significant achievement for JelikaLite. Our groundbreaking study, “Transcranial Photobiomodulation in Children Aged 2–6 Years: A Randomized Sham-Controlled Clinical Trial Assessing Safety, Efficacy, and Impact on Autism Spectrum Disorder Symptoms and Brain Electrophysiology,” has been published in Frontiers in Neurology 📚.
  • JelikaLite participated in Floreo VR’s inaugural virtual roundtable. A technology innovations such as Virtual Reality and wearables have begun to transform the delivery of behavioral therapy and developmental services for neurodiverse populations. Evidence demonstrates high levels of engagement among learners and the potential for improved outcomes. This panel discussed key trends, implications for therapy providers, what’s needed for further adoption, and the promise of these technologies.

Recent Comments

    Archives

    • April 2026
    • January 2025
    • September 2024
    • May 2024
    • November 2023
    • May 2023
    • February 2023
    • January 2023
    • April 2022
    • January 2022
    • December 2021
    • October 2021
    • August 2021
    • June 2021
    • March 2021

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    JelikaLite

    Company

    • Products
    • Science
    • Autism
    • Company
    • Press & News

    Rules

    • Disclaimer
    • Privacy Policy

    Social

    NSF
    • linkedin
    Copyright ©2026 jelikalite. All rights reserved.